Recent advances in biotechnology have improved the efficacy and safety of passive immunity: - Monoclonal Antibodies: These are engineered to target specific pathogens and have been used to treat diseases like COVID-19. - Hyperimmune Globulin: Derived from plasma donors with high levels of specific antibodies, these preparations are used for diseases such as Ebola.
